Group 1 - The company approved a share repurchase plan with a budget between RMB 10 million and RMB 20 million, with a maximum repurchase price of RMB 9.53 per share, to be executed within 12 months [1] - As of July 31, 2025, the company has repurchased a total of 265,516 shares, amounting to RMB 1,967,393.92, which is approximately 0.097% of the total share capital of 274,400,000 shares [2] - The company received a loan commitment letter from China Merchants Bank for RMB 16.2 million, with a 36-month term, specifically for the purpose of financing the share repurchase [2] Group 2 - The company will implement the share repurchase based on market conditions and the availability of funds, ensuring compliance with relevant laws and regulations [2]
南新制药: 关于取得股票回购专项贷款承诺函的公告